Cargando…

Human papillomavirus vaccination in the European Union/European Economic Area and globally: a moral dilemma

While many European Union/European Economic Area (EU/EEA) countries recently expanded human papillomavirus (HPV) vaccination to boys, HPV vaccine supply is currently limited for girls in low- and middle-income countries (LMIC) that are severely affected by HPV. Globally, about 50% of countries have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Colzani, Edoardo, Johansen, Kari, Johnson, Helen, Pastore Celentano, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8728487/ https://www.ncbi.nlm.nih.gov/pubmed/34915976 http://dx.doi.org/10.2807/1560-7917.ES.2021.26.50.2001659

Ejemplares similares

Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area
por: van den Wijngaard, Cees C, et al.
Publicado: (2017)

Prevention of human rabies: a challenge for the European Union and the European Economic Area
por: Gossner, Céline M, et al.
Publicado: (2020)

Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016
por: Harvala, Heli, et al.
Publicado: (2017)

Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020
por: Johnson, Helen C, et al.
Publicado: (2020)

Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization’s global health sector strategy core indicators and scaling up key interventions
por: Duffell, Erika F, et al.
Publicado: (2017)

Bluetongue Epidemiology in the European Union
por: Saegerman, Claude, et al.
Publicado: (2008)

Measles among migrants in the European Union and the European Economic Area
por: Williams, Gemma A., et al.
Publicado: (2015)

Rapidly increasing cumulative incidence of coronavirus disease (COVID-19) in the European Union/European Economic Area and the United Kingdom, 1 January to 15 March 2020
por: Kinross, Pete, et al.
Publicado: (2020)

Tuberculosis among migrant populations in the European Union and the European Economic Area
por: Odone, Anna, et al.
Publicado: (2015)

Consumption of cephalosporins in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Consumption of penicillins in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Reduction in undiagnosed HIV infection in the European Union/European Economic Area, 2012 to 2016
por: van Sighem, Ard, et al.
Publicado: (2017)

Tuberculosis in the European Union/European Economic Area: much progress, still many challenges
por: Guthmann, Jean-Paul, et al.
Publicado: (2019)

TB management in the European Union/European Economic Area: a multi-centre survey
por: Sotgiu, G., et al.
Publicado: (2021)

Change-points in antibiotic consumption in the community, European Union/European Economic Area, 1997–2017
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997–2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Quality appraisal of antibiotic consumption in the community, European Union/European Economic Area, 2009 and 2017
por: Adriaenssens, Niels, et al.
Publicado: (2021)

Identifying components for programmatic latent tuberculosis infection control in the European Union
por: Sandgren, Andreas, et al.
Publicado: (2016)

Will we reach the Sustainable Development Goals target for tuberculosis in the European Union/European Economic Area by 2030?
por: Merk, Hanna, et al.
Publicado: (2019)

Monitoring the progress achieved towards ending tuberculosis in the European Union/European Economic Area, 2018 to 2021
por: Cristea, Veronica, et al.
Publicado: (2023)

Using doxycycline for prophylaxis of bacterial sexually transmitted infections: considerations for the European Union and European Economic Area
por: Mårdh, Otilia, et al.
Publicado: (2023)

West Nile and Usutu Virus Infections and Challenges to Blood Safety in the European Union
por: Domanović, Dragoslav, et al.
Publicado: (2019)

Economic citizenship in the European Union : employment relations in the new Europe
por: Teague, Paul
Publicado: (1999)

Exploring Integration of Care for Children Living with Complex Care Needs across the European Union and European Economic Area
por: Brenner, Maria, et al.
Publicado: (2017)

Estimating HIV incidence and number of undiagnosed individuals living with HIV in the European Union/European Economic Area, 2015
por: Pharris, Anastasia, et al.
Publicado: (2016)

Health crisis in Venezuela: Status of communicable diseases and implications for the European Union and European Economic Area, May 2019
por: Espinosa, Laura, et al.
Publicado: (2019)

Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017: data collection, management and analysis
por: Bruyndonckx, Robin, et al.
Publicado: (2021)

Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997–2017
por: Versporten, Ann, et al.
Publicado: (2021)

Biosimilars entering the clinic without animal studies: A paradigm shift in the European Union
por: van Aerts, Leon AGJM, et al.
Publicado: (2014)

Development of a public health emergency preparedness competency model for European Union countries
por: Stoto, Michael A., et al.
Publicado: (2018)

Efficiency or compensation? The global economic crisis and the development of the European Union’s social policy
por: Lammers, Imke, et al.
Publicado: (2018)

Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products
por: Dulak, Józef, et al.
Publicado: (2023)

Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017
por: Kohlenberg, Anke, et al.
Publicado: (2018)

Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013
por: Cassini, Alessandro, et al.
Publicado: (2018)

Enduring the great recession: Economic integration in the European Union
por: Peritz, Lauren, et al.
Publicado: (2021)

Sustainable economic development in the European Union and COVID-19
por: Vavoura, Chara, et al.
Publicado: (2021)

Promoting Safe Early Clinical Research of Novel Drug Candidates: A European Union Regulatory Perspective
por: Ponzano, Stefano, et al.
Publicado: (2017)

The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area
por: Cole, Michelle J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uicn4aqh7hkno18jhltb75qba9